InsidersTradesSigma
Track the Tandem Diabetes Care, Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on US US, under the authority of SEC (Form 4). The latest transaction was reported on 17 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: MARK NOVARA. The full history is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Tandem Diabetes Care, Inc. is a company focused on developing medical devices for diabetes management. It concentrates on innovative solutions to enhance the quality of life for individuals with diabetes.